GUSBP3 (Gene)

Id:dd40eb3d-0387-57e9-9d0e-ed11cfe63887

Hgnc:HGNC:37301

Entrez:653188

Description:GUSB pseudogene 3

Predicted to enable beta-glucuronidase activity; carbohydrate binding activity; and signaling receptor binding activity. Predicted to be involved in glucuronoside catabolic process. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GUSBP3's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GUSBP3.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GUSBP3.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GUSBP3.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GUSBP3.

Results found

Linked to

	Label	Description
	GSE252944 AKT inhibition 7 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 5 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 10 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE229344 CYB5R3 overexpression 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE249471 bms LNCaP M 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE237216 STAT1 knockout RPMI-8226 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140768 BMI1 inhibition 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 13 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 5 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 10 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE229344 CYB5R3 overexpression 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE249471 bms LNCaP M 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE237216 STAT1 knockout RPMI-8226 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE140768 BMI1 inhibition 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE140758 MDM2 inhibition 4 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 sulforaphane 3 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.